Skip to main content
. Author manuscript; available in PMC: 2011 Jun 6.
Published in final edited form as: Clin Endocrinol (Oxf). 2008 Aug 15;70(5):698–705. doi: 10.1111/j.1365-2265.2008.03375.x

Table 1.

Characteristics of the study sample

Characteristic Men (n = 458) Women (n = 393)
Age (years) 46 (41–51) 51 (44–57)
Blood pressure (mmHg)
 Systolic 126 (119–136) 123 (111–135)
 Diastolic 79 (74–85) 75 (68–82)
Smoking (%) 11·8 10·8
Body mass index (kg/m2) 27·5 (25·2–30·3) 25·5 (22·55–29·9)
Total cholesterol (mg/dl) 199·5 (175–224) 211 (183–235)
HDL cholesterol (mg/dl) 42 (36–50) 58 (46–68)
Triglycerides (mg/dl) 125· ·5 (91–179) 114 (80–148)
Waist circumference (cm) 95·3 (88·9–104·1) 81·3 (73·7–91·4)
Metabolic syndrome* (%) 35 25
Resistin (ng/ml) 5·2 (3·87–6·87) 5·8 (4·42–7·84)
C-reactive protein (mg/dl) 1·1 (0·5–2) 1·4 (0·6–3·7)
Soluble TNF receptor 2 (ng/ml) 1·64 (1·41–1·95) 1·68 (1·37–2·0)
Interleukin-6 (pg/ml) 1·24 (0·79–1·87) 1·29 (0·82–2·1)
Leptin (ng/ml) 5·59 (3·28–8·75) 16·20 (9·76–27·21)
Adiponectin (μg/ml) 13·09 (8·92–17·78) 21·16 (14·95–28·40)
Coronary artery calcification (CAC)
 Mean score (± SD) 128·14 (335·46) 43·1 (136·23)
 Median (IQR) 7 (1–80) 1 (0–14)
 > 70th percentile (%) 40·1 39·1

HDL, high density lipoprotein; TNF, tumour necrosis factor; IQR, interquartile range.

Values are given as median (IQR) unless stated otherwise.

*

Metabolic syndrome according to the revised National Cholesterol Education Program (NCEP) definition using glucose cut-point of 100 mg/dl.